In the latest quarter, 11 analysts provided ratings for Edwards Lifesciences EW, showcasing a mix of bullish and bearish ...

EW stock is on investors' radar courtesy to the promising structural heart opportunities post the divestment of the Critical Care arm.

Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO. The Irvine-based medical device maker last week announced ...

Today, Benzinga's options scanner spotted 8 options trades for Edwards Lifesciences. This is not a typical pattern. The ...

US medical device giant Edwards Lifesciences has said patients are experiencing “outstanding one-year outcomes” and lower rates of mortality after treatment with its SAPIEN 3 RESILIA heart valve.

Stifel analysts upgraded Edwards Lifesciences (NYSE:EW) stock from Hold to Buy, citing potential growth acceleration in the Transcatheter Aortic Valve Replacement (TAVR) market. The firm also ...

Edwards Lifesciences EW is developing the ... and the 24.4% growth of the S&P 500 composite. The renowned global medical device company has a market capitalization of $41.90 billion.

The Global Medical Device Technology market industry is experiencing significant growth due to rapid technological advancements US, NY, UNITED STATES, January 22, 2025 /EINPresswire / -- Global ...